Table 3. Univariable and multivariable Cox regression analysis of the three-lncRNA signature and overall survival in each dataset.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI of HR | P-Value | HR | 95% CI of HR | P-value | |
Training dataset (n=213) | ||||||
Train score | 2.718 | 2.016–3.666 | 5.54E-11 | 2.528 | 1.735–3.683 | 1.36E-06 |
Age (old/young) | 1.035 | 0.648–1.654 | 0.884 | 0.860 | 0.499–1.482 | 0.588 |
Gender (male/female) | 0.835 | 0.489–1.424 | 0.508 | 0.892 | 0.456–1.744 | 0.739 |
Pathologic stage (Stage III_IV/I_II) | 1.558 | 0.864–2.808 | 0.140 | 1.536 | 0.751–3.145 | 0.240 |
Alcohol history documented (Yes/No) | 1.027 | 0.629–1.676 | 0.915 | 0.992 | 0.548–1.796 | 0.979 |
pN (positive/negative) | 0.735 | 0.334–1.615 | 0.443 | 0.709 | 0.238–2.114 | 0.537 |
Testing dataset (n=212) | ||||||
Test score | 1.457 | 1.093–1.942 | 0.010 | 2.224 | 1.194–4.139 | 0.012 |
Age (old/young) | 1.540 | 0.947–2.505 | 0.082 | 1.210 | 0.655–2.236 | 0.543 |
Gender (male/female) | 0.783 | 0.480–1.277 | 0.327 | 1.178 | 0.592–2.346 | 0.640 |
Pathologic stage (Stage III_IV/I_II) | 1.476 | 0.773–2.817 | 0.238 | 2.169 | 0.870–5.407 | 0.097 |
Alcohol history documented (Yes/No) | 0.795 | 0.489–1.293 | 0.355 | 0.806 | 0.404–1.609 | 0.541 |
pN (positive/negative) | 0.542 | 0.292–1.007 | 0.053 | 0.215 | 0.089–0.516 | 0.001 |
Entire dataset (n=425) | ||||||
Entire score | 1.770 | 1.481–2.115 | 3.49E-10 | 2.096 | 1.574–2.790 | 4.02E-07 |
Age (old/young) | 1.286 | 0.918–1.802 | 0.144 | 1.073 | 0.722–1.595 | 0.727 |
Gender (male/female) | 0.837 | 0.588–1.192 | 0.325 | 1.124 | 0.704–1.796 | 0.624 |
Pathologic stage (Stage III_IV/I_II) | 1.494 | 0.969–2.305 | 0.069 | 1.787 | 1.022–3.122 | 0.0418 |
Alcohol history documented (Yes/No) | 0.893 | 0.633–1.258 | 0.516 | 0.842 | 0.542–1.310 | 0.446 |
pN (positive/negative) | 0.640 | 0.396–1.034 | 0.068 | 0.356 | 0.182–0.695 | 0.002 |